Stock Track | Smith & Nephew Soars 8.26% as Strong U.S. Orthopedics Sales Impress

Stock Track

Feb 25, 2025

Smith & Nephew PLC (SNN) saw its stock soar 8.26% on Tuesday during the 24-hour trading session, outperforming the broader market.

The medical technology company's strong performance was driven by impressive results, particularly in its U.S. orthopedics business. Smith & Nephew's U.S. orthopedics division posted underlying growth of 6% in the fourth quarter, exceeding expectations and boosted by strength in its hips and knees products.

Analysts at RBC Capital Markets commended the company's results, noting that the reassuring strength in the U.S. orthopedics segment will be welcomed by investors. Smith & Nephew also provided a 2025 outlook in line with consensus expectations and anticipates headwinds in China to clear through the first quarter, consistent with previous guidance.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1102732382"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1102732382\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1102732382?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-25 16:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1102732382","market":"hk","top_or_hot":-1,"title":"Stock Track | Smith & Nephew Soars 8.26% as Strong U.S. Orthopedics Sales Impress","media":"Stock Track","content":"<p>Smith & Nephew PLC (SNN) saw its stock soar 8.26% on Tuesday during the 24-hour trading session, outperforming the broader market.</p>\n\n<p>The medical technology company's strong performance was driven by impressive results, particularly in its U.S. orthopedics business. Smith & Nephew's U.S. orthopedics division posted underlying growth of 6% in the fourth quarter, exceeding expectations and boosted by strength in its hips and knees products.</p>\n\n<p>Analysts at RBC Capital Markets commended the company's results, noting that the reassuring strength in the U.S. orthopedics segment will be welcomed by investors. Smith & Nephew also provided a 2025 outlook in line with consensus expectations and anticipates headwinds in China to clear through the first quarter, consistent with previous guidance.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Smith & Nephew Soars 8.26% as Strong U.S. Orthopedics Sales Impress</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Smith & Nephew Soars 8.26% as Strong U.S. Orthopedics Sales Impress\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-25 16:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Smith & Nephew PLC (SNN) saw its stock soar 8.26% on Tuesday during the 24-hour trading session, outperforming the broader market.</p>\n\n<p>The medical technology company's strong performance was driven by impressive results, particularly in its U.S. orthopedics business. Smith & Nephew's U.S. orthopedics division posted underlying growth of 6% in the fourth quarter, exceeding expectations and boosted by strength in its hips and knees products.</p>\n\n<p>Analysts at RBC Capital Markets commended the company's results, noting that the reassuring strength in the U.S. orthopedics segment will be welcomed by investors. Smith & Nephew also provided a 2025 outlook in line with consensus expectations and anticipates headwinds in China to clear through the first quarter, consistent with previous guidance.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SNN","symbol_name":"Smith & Nephew PLC ADS","start_time":0,"source_url":"","article_id":"1102732382","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1102732382","pubTimestamp":1740472590,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Smith & Nephew PLC  saw its stock soar 8.26% on Tuesday during the 24-hour trading session, outperforming the broader market.The medical technology company's strong performance was driven by impressive results, particularly in its U.S. orthopedics business. Smith & Nephew's U.S. orthopedics division posted underlying growth of 6% in the fourth quarter, exceeding expectations and boosted by strength in its hips and knees products.Analysts at RBC Capital Markets commended the company's results, no","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SNN":"Smith & Nephew PLC ADS"},"translate_title":"由于美国骨科销售强劲，施乐辉股价飙升8.26%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SNN":1},"content_text":"Smith & Nephew PLC (SNN) saw its stock soar 8.26% on Tuesday during the 24-hour trading session, outperforming the broader market.\nThe medical technology company's strong performance was driven by impressive results, particularly in its U.S. orthopedics business. Smith & Nephew's U.S. orthopedics division posted underlying growth of 6% in the fourth quarter, exceeding expectations and boosted by strength in its hips and knees products.\nAnalysts at RBC Capital Markets commended the company's results, noting that the reassuring strength in the U.S. orthopedics segment will be welcomed by investors. Smith & Nephew also provided a 2025 outlook in line with consensus expectations and anticipates headwinds in China to clear through the first quarter, consistent with previous guidance.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}